Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Solomon

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|January 6, 2026
A multidimensional workflow profiling of allogeneic virus-specific T cell therapies reveals potency-linked signaturesCorey Smith, Vijayendra Dasari, Sriganesh Srihari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2018
Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialCorey Smith, Leone Beagley, Sweera Rehan, et al.
Nature Communications|August 8, 2023
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing miceVijayendra Dasari, Lisa K McNeil, Kirrilee Beckett, et al.
Clinical & Translational Immunology|June 11, 2025
Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ diseaseAndrea S Henden, Katie E Lineburg, Archana Panikkar, et al.
Plos Pathogens|February 14, 2022
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsArchana Panikkar, Katie E Lineburg, Jyothy Raju, et al.
Open Forum Infectious Diseases|January 6, 2022
Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USAVlad Novitsky, Jon Steingrimsson, Fizza S Gillani, et al.
JAMA|October 13, 2025
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial IntelligenceDerek C Angus, Rohan Khera, Tracy Lieu, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|January 6, 2026
A multidimensional workflow profiling of allogeneic virus-specific T cell therapies reveals potency-linked signaturesCorey Smith, Vijayendra Dasari, Sriganesh Srihari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2018
Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialCorey Smith, Leone Beagley, Sweera Rehan, et al.
Nature Communications|August 8, 2023
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing miceVijayendra Dasari, Lisa K McNeil, Kirrilee Beckett, et al.
Clinical & Translational Immunology|June 11, 2025
Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ diseaseAndrea S Henden, Katie E Lineburg, Archana Panikkar, et al.
Plos Pathogens|February 14, 2022
SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsArchana Panikkar, Katie E Lineburg, Jyothy Raju, et al.
Open Forum Infectious Diseases|January 6, 2022
Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USAVlad Novitsky, Jon Steingrimsson, Fizza S Gillani, et al.
JAMA|October 13, 2025
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial IntelligenceDerek C Angus, Rohan Khera, Tracy Lieu, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Pageof 4